FET's Strong Backlog and Strategy Execution Drive Long-Term Growth
zacks.com
Want to monitor NVCR?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor NVCRwe are a commercial-stage oncology company developing a novel, proprietary therapy called tumor treating fields, or ttfields, for the treatment of solid tumor cancers.